New Sava Bridge in Belgrade – Bridge Superstructure – Design and execution aspects
ce/papers · 2026-09 · 9 (2-3) · 1402-1407
DOI: 10.1002/cepa.70309 ↗Kurz gefasst
Fachartikel in der Zeitschrift ce/papers, online erschienen am 14.09.2026. Verfasst von Slobodan Jaćović und 7 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
New Sava Bridge Project started in 2020 as a Design‐Build contract between the Republic of Serbia and the Chinese company PowerChina International, for the building of the new, modern bridge with the higher capacity at the same location of the Old Sava Bridge. Now that most of the old bridge has been removed, Design for Execution finished, extensive construction works are advancing for the building of the New Bridge. The New Sava bridge shall be 420m long, with 166m main span over Sava River navigation profile. The superstructure of the bridge is designed as aesthetic, innovative continuous composite girder, supported with two asymmetric arches in the main span. This Paper presents design and execution challenges in construction of modern bridge structures in urban environments, as a Project of the replacement of old bridge.
Zitieren
APA
Jaćović, S., Xin, L., Kukaras, D., Kajević, E., Marković, Z., Vujičić, J., Mandić, M., & Ristić, V. (2026). New Sava Bridge in Belgrade – Bridge Superstructure – Design and execution aspects. ce/papers, 9(2-3), 1402-1407. https://doi.org/10.1002/cepa.70309
Vancouver
Jaćović S, Xin L, Kukaras D, Kajević E, Marković Z, Vujičić J, et al. New Sava Bridge in Belgrade – Bridge Superstructure – Design and execution aspects. ce/papers. 2026;9(2-3):1402-1407. doi:10.1002/cepa.70309
BibTeX
@article{Jaovi2026,
author = {Jaćović, Slobodan and Xin, Li and Kukaras, Danijel and Kajević, Elvir and Marković, Zlatko and Vujičić, Jovana and Mandić, Mirjana and Ristić, Vule},
title = {New Sava Bridge in Belgrade – Bridge Superstructure – Design and execution aspects},
journal = {ce/papers},
year = {2026},
volume = {9},
number = {2-3},
pages = {1402--1407},
doi = {10.1002/cepa.70309}
}
EUVIMED